Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M O'Bryan

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1995
Short-course FAC-M versus 1 year of CMFVP in node-positive, hormone receptor-negative breast cancer: an intergroup studyG T Budd, S Green, R M O'Bryan, et al.
Cancer Treatment Reports|June 1, 1987
Lack of benefit of adjunctive chemotherapy in stage I malignant melanoma: a Southwest Oncology Group StudyB L Tranum, D Dixon, J Quagliana, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993
One versus 2 years of CMFVP adjuvant chemotherapy in axillary node-positive and estrogen receptor-negative patients: a Southwest Oncology Group studyS E Rivkin, S Green, B Metch, et al.
Cancer|May 1, 1977
Dose response evaluation of adriamycin in human neoplasiaR M O'Bryan, L H Baker, J E Gottlieb, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1986
Effect of alternating combination chemotherapy on survival of ambulatory patients with metastatic large-cell and adenocarcinoma of the lung. A Southwest Oncology Group StudyT P Miller, T T Chen, C A Coltman, et al.
American Journal of Clinical Oncology|April 1, 1983
Adriamycin versus adriamycin plus cis-diamminedichloroplatinum (DDP) in advanced transitional cell bladder carcinoma. A Southwest Oncology Group studyR Gagliano, H Levin, M N El-Bolkainy, et al.
Cancer Treatment Reports|February 1, 1976
Role of DTIC (NSC-45388) in the chemotherapy of sarcomasJ A Gottlieb, R S Benjamin, L H Baker, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1995
Short-course FAC-M versus 1 year of CMFVP in node-positive, hormone receptor-negative breast cancer: an intergroup studyG T Budd, S Green, R M O'Bryan, et al.
Cancer Treatment Reports|June 1, 1987
Lack of benefit of adjunctive chemotherapy in stage I malignant melanoma: a Southwest Oncology Group StudyB L Tranum, D Dixon, J Quagliana, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993
One versus 2 years of CMFVP adjuvant chemotherapy in axillary node-positive and estrogen receptor-negative patients: a Southwest Oncology Group studyS E Rivkin, S Green, B Metch, et al.
Cancer|May 1, 1977
Dose response evaluation of adriamycin in human neoplasiaR M O'Bryan, L H Baker, J E Gottlieb, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1986
Effect of alternating combination chemotherapy on survival of ambulatory patients with metastatic large-cell and adenocarcinoma of the lung. A Southwest Oncology Group StudyT P Miller, T T Chen, C A Coltman, et al.
American Journal of Clinical Oncology|April 1, 1983
Adriamycin versus adriamycin plus cis-diamminedichloroplatinum (DDP) in advanced transitional cell bladder carcinoma. A Southwest Oncology Group studyR Gagliano, H Levin, M N El-Bolkainy, et al.
Cancer Treatment Reports|February 1, 1976
Role of DTIC (NSC-45388) in the chemotherapy of sarcomasJ A Gottlieb, R S Benjamin, L H Baker, et al.
Pageof 3